Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,069 shares at $2.63 ($3K) on 2022-04-18, disclosed to the SEC on 2022-05-06.
Scheduled purchase ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.71 | 94 | $255 | 9.1% |
| 2 | $2.63 | 94 | $247 | 8.9% |
| 3 | $2.69 | 94 | $253 | 9.1% |
| 4 | $2.74 | 94 | $258 | 9.2% |
| 5 | $2.75 | 94 | $259 | 9.3% |
| 6 | $2.73 | 94 |
| $257 |
| 9.2% |
| 7 | $2.62 | 101 | $265 | 9.5% |
| 8 | $2.53 | 101 | $256 | 9.2% |
| 9 | $2.41 | 101 | $243 | 8.7% |
| 10 | $2.51 | 101 | $254 | 9.1% |
| 11 | $2.44 | 101 | $246 | 8.8% |
| Total | $2.61 avg | 1,069 | $3K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |